The Hospital Clínic-IDIBAPS leads the largest European study to date on liver disease

by Fundació Clínic per a la Recerca Biomèdica

The project, funded by the European Union and endowed with a budget of 24.8 million euros, aims to identify a large set of biomarkers that allow liver disease to be detected in the earliest stages, an...

Read more

Hospital Clínic-IDIBAPS researchers review adjuvant treatment with immunotherapy and vaccines for liver cancer

by Fundació Clínic per a la Recerca Biomèdica

The combination of surgery with adjuvant immunotherapy, after surgery, was shown to improve disease-free survival rates in the last IMbrave 050 phase III study

Read more

A European study in people with the participation of Clínic-IDIBAPS shows that treatment with the drug Abatacept reduces the risk of developing rheumatoid arthritis

by Fundació Clínic per a la Recerca Biomèdica

Published in the journal The Lancet, the study presents the results of Abatacept, a drug that modulates the activation of T cells, which play a key role in the progression of the disease.

Read more

A European project led by IDIBAPS will test a diagnostic genomic test for breast cancer to improve patients' quality of life

by Fundació Clínic per a la Recerca Biomèdica

The DEFINITIVE project, led by IDIBAPS, will be conducted across 44 hospitals in a total of 7 European and associated countries to demonstrate that use of genomic test HER2DX® improves quality of lif...

Read more

The PEACHD European project is launched to improve cancer prevention in specific vulnerable groups in Europe

by Fundació Clínic per a la Recerca Biomèdica

Endowed with 1.25 million euros, the project is coordinated by IDIBAPS’ Clinical Addictions Research Group (GRAC-GRE), which is led by Hugo López-Pelayo, a researcher and medical specialist at Hosp...

Read more

Clínic-IDIBAPS researchers detect an increase in mental health problems among female adolescents after lockdown

by Fundació Clínic per a la Recerca Biomèdica

The study shows an upward trend in emergency admissions related to eating disorders, self-harm and suicide ideation and attempts, particularly among female adolescents.

Read more

Presentation of the first model to predict response to CAR T-cell therapy in multiple myeloma

by Fundació Clínic per a la Recerca Biomèdica

An international team, co-led by the Hospital Clínic-IDIBAPS, has identified four biomarkers that determine the risk of the recurrence of this cancer after CAR T-cell therapy.

Read more

The cellular atlas of the human tonsil, a key to the understanding of the immune system and diseases such as leukaemias and lymphomas

by Fundació Clínic per a la Recerca Biomèdica

The research provides the most comprehensive cellular map to date of the human tonsil, increasing our understanding of immune response to disease, and perception of immune system related diseases such...

Read more

Individualised ventilation strategies reduce postoperative pulmonary complications in thoracic surgery patients

by Fundació Clínic per a la Recerca Biomèdica

It has been shown that the administration of individualised pulmonary ventilation strategies for each patient, adjusting respiratory support to individual needs during the intraoperative and immediate...

Read more

A Hospital Clínic-IDIBAPS team discovers two proteins that regulate muscle mass during fasting

by Fundació Clínic per a la Recerca Biomèdica

Research team has described that the ZEB1 and ZEB2 proteins oppositely regulate muscle adaptation to energy needs during fasting.

Read more

IDIBAPS receives 2.5 million euros from the Fortalece-Salud programme to promote biomedical research

by Fundació Clínic per a la Recerca Biomèdica

The goal of the KAIROS project, driven by 6 Clínic-IDIBAPS research groups, will be to enhance molecular and genetic knowledge about various diseases and facilitate the translation of this knowledge ...

Read more

The European Union launches the THRIVE project to improve the prognosis of children and adults with liver cancer

by Fundació Clínic per a la Recerca Biomèdica

The ultimate goal of THRIVE is to improve the survival rates of both paediatric and adult liver cancer patients by understanding at-risk populations and tumour-host interactions and developing biomark...

Read more
Subscribe to Directory
Write an Article

Recent News

El diagnóstico genético neonatal mejor...

Un estudio con datos de los últimos 35 años, ind...

Más de 1.500 cambios epigenéticos en e...

Un equipo de investigadores de la Universidad Juli...

Tuneable reverse photochromes in the sol...

A new technique allows the design of solid materia...

Highlight

Eosinófilos. ¿Qué significa tener val...

by Labo'Life

​En nuestro post hablamos sobre este interesante tipo de célula del...

Un estudio de INCLIVA muestra el efecto ...

by INCLIVA

Han desarrollado un estudio para evaluar la correlación entre el teji...

Photos Stream